Eroding Judicial Deference to the FDA - Consequences for Public Health
N Engl J Med
.
2023 Mar 16;388(11):963-966.
doi: 10.1056/NEJMp2215193.
Epub 2023 Mar 11.
Authors
C Joseph Ross Daval
1
,
Liam Bendicksen
1
,
Aaron S Kesselheim
1
Affiliation
1
From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
PMID:
36912543
DOI:
10.1056/NEJMp2215193
No abstract available
MeSH terms
Government Regulation*
Humans
Public Health* / legislation & jurisprudence
United States
United States Food and Drug Administration* / legislation & jurisprudence